Glory Biomedical

Glory Biomedical, officially known as Beijing Glory Biomedical Technology Co., Ltd., is a prominent biotechnology company specializing in regenerative medicine and tissue engineering. Founded in 2012 and headquartered in Beijing, the company focuses on the development of advanced biomaterials derived from porcine small intestinal submucosa (SIS). Their proprietary technology platform produces extracellular matrix (ECM) scaffolds that promote natural tissue regeneration and are fully absorbable by the human body. Glory Biomedical's product portfolio includes surgical meshes for hernia repair, dural patches for neurosurgery, and specialized wound dressings, many of which have received regulatory approval in China. The company aims to replace traditional synthetic implants with biological solutions that reduce long-term complications and improve patient outcomes.